FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/04/032807 [Registered on: 13/04/2021] Trial Registered Prospectively
Last Modified On: 26/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Evaluation of effect of Shallaki, Lepa and Janu Vasti in Patients With Knee Joint Osteoarthritis 
Scientific Title of Study   Clinical Evaluation of Shallaki and its comparative synergistic effect with Lepa and Janu Vasti in Janusandhigata Vata with special reference to Knee Joint Osteoarthritis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
IEC / ACA / 2020 /3 -23  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  A M H S Attanayake 
Designation  MD Scholar 
Affiliation  National Institute of Ayurveda 
Address  Post Graduate Department of Kayachikitsa National Institute of Ayurveda Jorawar Singh Gate Amer Road Jaipur
142 Govind Nagar West Amer road Jaipur Rajasthan
Jaipur
RAJASTHAN
302002
India 
Phone  9119218397  
Fax  911412635816  
Email  harshamed@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Abhishek Upadhyay 
Designation  Lecturer 
Affiliation  National Institute of Ayurveda 
Address  Post Graduate Department of Kayachikitsa National Institute of Ayurveda Jorawar Singh Gate Amer Road Jaipur
Post Graduate Department of Kayachikitsa National Institute of Ayurveda Jorawar Singh Gate Amer Road Jaipur
Jaipur
RAJASTHAN
302002
India 
Phone  9915613039  
Fax    
Email  dr.abhishek82@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Abhishek Upadhyay 
Designation  Lecturer 
Affiliation  National Institute of Ayurveda 
Address  Post Graduate Department of Kayachikitsa National Institute of Ayurveda Jorawar Singh Gate Amer Road Jaipur
Post Graduate Department of Kayachikitsa National Institute of Ayurveda Jorawar Singh Gate Amer Road Jaipur
Jaipur
RAJASTHAN
302002
India 
Phone  9915613039  
Fax    
Email  dr.abhishek82@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda 
 
Primary Sponsor  
Name  National Institute of Ayurvea 
Address  Jorawar Singh Gate, Amer Road,Jaipur, 302002 
Type of Sponsor  Other [Ayurveda University] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Abhishek Upadhyay  Post graduate Department of Kayachikitsa, National Institute of Ayurveda, Jorawar Singh gate, Amer road, Jaipur, 302002 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr A M H S Attanayake  National Institute of Ayurveda  Jorawar Singh Gate Amer Road Jaipur 302002
Jaipur
RAJASTHAN 
9119218397

harshamed@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, National Institute of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M170||Bilateral primary osteoarthritis of knee. Ayurveda Condition: Janusandhigata Vata,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Shallaki Tablets   Shallaki tablets 1 gram TDS orally 15 days,  
Comparator Agent  Shallaki tablets with Ketakyadi Janu Vasti  Internal application of shallaki 1gram TDS for 15 days and external application of Ketakyadi Taila 250ml Janu Vasti for 15 days 
Comparator Agent  Shallaki Tablets with Koladi Lepa  Internal Application of Shallaki tablet 1 gram TDS for 15 days and external application of Koladi Lepa 30 gram twice a day for 15 days  
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Patients in the age group of 40 to 70 years of either sex.
2. Patients having signs and symptoms of Janusandhigata Vata of Shotha (edema), Vatapurnadriti Sparsha (on palpation revealed as air filled bag) and pain with Prasaran (extension) and Akunchan (flexion) movements.
3. Patients having chronicity of disease Janusandhigata Vata (KOA) for less than 5 years.
4. Patients willing to sign consent form for the clinical trial.
5. Kellgren Lawrence (Radiological scale) of e” ≥2
 
 
ExclusionCriteria 
Details  1. Patients below 40 years and above 70 years of age.
2. Patients of Rheumatoid arthritis, Ankylosing and traumatic arthritis.
3. Patients suffering from paralysis, muscular dystrophy, polio affected persons or persons
with bony deformities
4. Patients having systemic conditions such as Tuberculosis, Brucellosis, Osteomyelitis,
Gouty Arthritis, Psoriatic Arthritis and Systemic Lupus Erythematosus
5. Patients having neoplasm of spine and other complicated diseases like CCF, DM,
Uncontrolled HTN, Unstable Angina, Recent MI etc.
6. Patients using anti-inflammatory medicines including Allopathic medicine and
AYUSH medicines.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in pain and stiffness
including signs and symptoms of Janusandhigata Vata of Shotha (edema), Vatapurnadriti Sparsha (on palpation revealed as air filled bag) and pain with Prasaran (extension), Akunchan (flexion) movements and improvement in Knee Injury and Osteoarthritis Outcome Score (KOOS) 
15 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement of range of motion  15 days 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   30/06/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   No Publication yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized, open label, parallel group, single centre, comparative clinical trial evaluating effect of Shallaki and its comparative synergistic effect with Lepa and Janu Vasti in Janusandhigata Vata with special reference to Knee joint Osteoarthritis. Null hypothesis of the study is there is no difference in the treatment outcome of Janusandhigata Vata with special reference to knee joint osteoarthritis when treated with three different interventions of Shallaki, Shallaki with Koladi Lepa or Shallaki with Ketakyadi Janu Vasti. Shallaki will be given 1 gram thrice a day for 15 days in one group and other group will be treated with shallaki 1 gram thrice a day with external application of 30 grams of Koladi Lepa twice a day for 15 days. Third group will be treated with Shallaki 1 gram thrice a day and Janu Vasti with Ketakyadi Taila (250 ml) once a day for 15 days. Site of study will be National Institute of Ayurveda, Jaipur, Rajasthan, India. Primary outcome of the study is reduction of pain and stiffness including sign and symptoms of Janusandhigata Vata of Shota (edema), Vatapurnadriti Sparsha ( on palpation revealed as air filled bag) and pain with Prasarana and Akunchana( extension and flexion) and improvement in Knee injury and osteoarthritis outcome score ( KOOS). Secondary outcome of the study is improvement in the range of motion.  
Close